IFNA1 and COVID-19: Clinical studies have reported a lack of IFN response despite robust cytokine and chemokine production in COVID-19 patients, consistent with the in vitro observation that SARS-CoV-2 infection does not induce significant IFN production (Arunachalam et al., 2020; Blanco-Melo et al., 2020).